Loading…

Endoglin - a marker of vascular endothelial cell proliferation in cancer

Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes...

Full description

Saved in:
Bibliographic Details
Published in:Contemporary oncology (Poznań, Poland) Poland), 2012-01, Vol.16 (1), p.68-71
Main Authors: Kopczynska, Ewa, Makarewicz, Roman
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3300-b6043b55272ab5e2137f9f2d9252024fe20658eebe0b519bb2dc6779f02f25943
cites
container_end_page 71
container_issue 1
container_start_page 68
container_title Contemporary oncology (Poznań, Poland)
container_volume 16
creator Kopczynska, Ewa
Makarewicz, Roman
description Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.
doi_str_mv 10.5114/wo.2012.27340
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3687377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2840068191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3300-b6043b55272ab5e2137f9f2d9252024fe20658eebe0b519bb2dc6779f02f25943</originalsourceid><addsrcrecordid>eNpVkEFLwzAYhoMobswdvQc8dyZfmia5CDKmEwZe9FySNtmiWVPTduK_N-Aunt4PXr6HhxehW0pWnNLy_juugFBYgWAluUBzKpUoSkbUZb5LkAVwqGZoOQzeEEKF5BVj12gGTEgpuZyj7aZr4z74DhdY46NOnzbh6PBJD80UdMI29-PBBq8DbmwIuE8xeGeTHn3scH5sdNfYdIOunA6DXZ5zgd6fNm_rbbF7fX5ZP-6KhjFCClORkhnOQYA23AJlwikHrcqmBEpngVRcWmssMZwqY6BtKiGUI-CAq5It0MMft5_M0baN7cakQ90nn-V_6qh9_b_p_KHex1PNKimYEBlwdwak-DXZYaw_4pS67FzTvEtFFROM_QI_vGaE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237619373</pqid></control><display><type>article</type><title>Endoglin - a marker of vascular endothelial cell proliferation in cancer</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kopczynska, Ewa ; Makarewicz, Roman</creator><creatorcontrib>Kopczynska, Ewa ; Makarewicz, Roman</creatorcontrib><description>Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.</description><identifier>ISSN: 1428-2526</identifier><identifier>EISSN: 1897-4309</identifier><identifier>DOI: 10.5114/wo.2012.27340</identifier><identifier>PMID: 23788858</identifier><language>eng</language><publisher>Poznan: Termedia Publishing House</publisher><subject>Review</subject><ispartof>Contemporary oncology (Poznań, Poland), 2012-01, Vol.16 (1), p.68-71</ispartof><rights>Copyright Termedia Publishing House 2012</rights><rights>Copyright © 2012 Termedia 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3300-b6043b55272ab5e2137f9f2d9252024fe20658eebe0b519bb2dc6779f02f25943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687377/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1237619373?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,44588,53789,53791</link.rule.ids></links><search><creatorcontrib>Kopczynska, Ewa</creatorcontrib><creatorcontrib>Makarewicz, Roman</creatorcontrib><title>Endoglin - a marker of vascular endothelial cell proliferation in cancer</title><title>Contemporary oncology (Poznań, Poland)</title><description>Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.</description><subject>Review</subject><issn>1428-2526</issn><issn>1897-4309</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpVkEFLwzAYhoMobswdvQc8dyZfmia5CDKmEwZe9FySNtmiWVPTduK_N-Aunt4PXr6HhxehW0pWnNLy_juugFBYgWAluUBzKpUoSkbUZb5LkAVwqGZoOQzeEEKF5BVj12gGTEgpuZyj7aZr4z74DhdY46NOnzbh6PBJD80UdMI29-PBBq8DbmwIuE8xeGeTHn3scH5sdNfYdIOunA6DXZ5zgd6fNm_rbbF7fX5ZP-6KhjFCClORkhnOQYA23AJlwikHrcqmBEpngVRcWmssMZwqY6BtKiGUI-CAq5It0MMft5_M0baN7cakQ90nn-V_6qh9_b_p_KHex1PNKimYEBlwdwak-DXZYaw_4pS67FzTvEtFFROM_QI_vGaE</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Kopczynska, Ewa</creator><creator>Makarewicz, Roman</creator><general>Termedia Publishing House</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20120101</creationdate><title>Endoglin - a marker of vascular endothelial cell proliferation in cancer</title><author>Kopczynska, Ewa ; Makarewicz, Roman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3300-b6043b55272ab5e2137f9f2d9252024fe20658eebe0b519bb2dc6779f02f25943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kopczynska, Ewa</creatorcontrib><creatorcontrib>Makarewicz, Roman</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Contemporary oncology (Poznań, Poland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kopczynska, Ewa</au><au>Makarewicz, Roman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endoglin - a marker of vascular endothelial cell proliferation in cancer</atitle><jtitle>Contemporary oncology (Poznań, Poland)</jtitle><date>2012-01-01</date><risdate>2012</risdate><volume>16</volume><issue>1</issue><spage>68</spage><epage>71</epage><pages>68-71</pages><issn>1428-2526</issn><eissn>1897-4309</eissn><abstract>Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.</abstract><cop>Poznan</cop><pub>Termedia Publishing House</pub><pmid>23788858</pmid><doi>10.5114/wo.2012.27340</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1428-2526
ispartof Contemporary oncology (Poznań, Poland), 2012-01, Vol.16 (1), p.68-71
issn 1428-2526
1897-4309
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3687377
source Publicly Available Content Database; PubMed Central
subjects Review
title Endoglin - a marker of vascular endothelial cell proliferation in cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A24%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endoglin%20-%20a%20marker%20of%20vascular%20endothelial%20cell%20proliferation%20in%20cancer&rft.jtitle=Contemporary%20oncology%20(Poznan%CC%81,%20Poland)&rft.au=Kopczynska,%20Ewa&rft.date=2012-01-01&rft.volume=16&rft.issue=1&rft.spage=68&rft.epage=71&rft.pages=68-71&rft.issn=1428-2526&rft.eissn=1897-4309&rft_id=info:doi/10.5114/wo.2012.27340&rft_dat=%3Cproquest_pubme%3E2840068191%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3300-b6043b55272ab5e2137f9f2d9252024fe20658eebe0b519bb2dc6779f02f25943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1237619373&rft_id=info:pmid/23788858&rfr_iscdi=true